Evidence map›Paper›PMID 34681636›Full record

ArticleInternational journal of molecular sciences2021

Short Daily Exposure to Environmental Enrichment, Fluoxetine, or Their Combination Reverses Deterioration of the Coat and Anhedonia Behaviors with Differential Effects on Hippocampal Neurogenesis in Chronically Stressed Mice.

Gerardo Bernabé Ramírez-Rodríguez, Nelly Maritza Vega-Rivera, David Meneses-San Juan, Leonardo Ortiz-López, Erika Montserrat Estrada-Camarena, Mónica Flores-Ramos

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Gerardo Bernabé Ramírez-RodríguezLaboratorio of Neurogenesis, Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría "Ramón de la Fuente Muñiz", Calzada México-Xochimilco 101, Mexico City C.P. 14370, Mexico.ORCID 0000-0003-3243-1588
Nelly Maritza Vega-RiveraLaboratorio of Neurpsicofarmacología, Dirección de Neurociencias, Instituto Nacional de Psiquiatría "Ramón de la Fuente Muñiz", Calzada México-Xochimilco 101, Mexico City C.P. 14370, Mexico.
David Meneses-San JuanLaboratorio of Neurogenesis, Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría "Ramón de la Fuente Muñiz", Calzada México-Xochimilco 101, Mexico City C.P. 14370, Mexico.
Leonardo Ortiz-LópezLaboratorio of Neurogenesis, Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría "Ramón de la Fuente Muñiz", Calzada México-Xochimilco 101, Mexico City C.P. 14370, Mexico.
Erika Montserrat Estrada-CamarenaLaboratorio of Neurpsicofarmacología, Dirección de Neurociencias, Instituto Nacional de Psiquiatría "Ramón de la Fuente Muñiz", Calzada México-Xochimilco 101, Mexico City C.P. 14370, Mexico.ORCID 0000-0001-6634-7494
Mónica Flores-RamosDirección de Enseñanza, Instituto Nacional de Psiquiatría "Ramón de la Fuente Muñiz", Calzada México-Xochimilco 101, Col. San Lorenzo Huipulco, Tlalpan, Mexico City C.P. 14370, Mexico.ORCID 0000-0002-2798-7605
Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz · MX

Funding

Consejo Nacional de Ciencia y Tecnología (CONACYT) 254773Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz SIC-2000
6 · The paper itself

Abstract

Depression is a neuropsychiatric disorder with a high impact on the worldwide population. To overcome depression, antidepressant drugs are the first line of treatment. However, pre-clinical studies have pointed out that antidepressants are not entirely efficacious and that the quality of the living environment after stress cessation may play a relevant role in increasing their efficacy. As it is unknown whether a short daily exposure to environmental enrichment during chronic stress and antidepressant treatment will be more effective than just the pharmacological treatment, this study analyzed the effects of fluoxetine, environmental enrichment, and their combination on depressive-associated behavior. Additionally, we investigated hippocampal neurogenesis in mice exposed to chronic mild stress. Our results indicate that fluoxetine reversed anhedonia. Besides, fluoxetine reversed the decrement of some events of the hippocampal neurogenic process caused by chronic mild stress. Conversely, short daily exposure to environmental enrichment changed the deterioration of the coat and anhedonia. Although, this environmental intervention did not produce significant changes in the neurogenic process affected by chronic mild stress, fluoxetine plus environmental enrichment showed similar effects to those caused by environmental enrichment to reverse depressive-like behaviors. Like fluoxetine, the combination reversed the declining number of Ki67, doublecortin, calretinin cells and mature newborn neurons. Finally, this study suggests that short daily exposure to environmental enrichment improves the effects of fluoxetine to reverse the deterioration of the coat and anhedonia in chronically stressed mice. In addition, the combination of fluoxetine with environmental enrichment produces more significant effects than those caused by fluoxetine alone on some events of the neurogenic process. Thus, environmental enrichment improves the benefits of pharmacological treatment by mechanisms that need to be clarified.

Indexed as

AnhedoniaAnimalsBehavior, AnimalCalbindin 2Cell ProliferationDoublecortin ProteinEnvironmentFemaleFluoxetineHippocampusKi-67 AntigenMiceMice, Inbred BALB CNeurogenesisSelective Serotonin Reuptake InhibitorsStress, PhysiologicalCalbindin 2Doublecortin ProteinFluoxetineKi-67 AntigenSelective Serotonin Reuptake Inhibitorsadult neurogenesischronic mild stressdepressionenvironmental enrichmentfluoxetinehippocampus

Identifiers

PMID34681636
PMCPMC8535985
OpenAlexW3207977523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.